Cost Effectiveness of Adding Natriuretic Peptid Type B to the Lee Index in Cardiovascular Risk for Non-Cardiac Surgery (Costo-Efectividad de Añadir el Péptido Natriurético Tipo B al Índice de Lee en la Evaluación del Riesgo Cardiovascular en Cirugía Mayor No Cardiaca) (Spanish)

A decision tree is used to assess the cost effectiveness of adding the type B natriuretic peptid to the revised Lee index of cardiovascular risk. The Lee=3 strategy is cost effective for a WTP lower than Col $11.292.903 at a cost per patient of Col $79.452. Lee strategy with a threshold of 3 has the best profile of cost effectiveness, but the results were very sensitive to the probability of cardio vascular events

MoreLess

Year of publication:	2011
Authors:	Gamboa, Oscar ; Chicaíza, Liliana ; García Molina, Mario
Publisher:	[S.l.] : SSRN
Subject:	Spanien \| Spain \| Herzkrankheit \| Heart disease \| Gesundheitskosten \| Health care costs

freely available

Full text |

More access options

doi.org

Check Google Scholar

In German libraries (KVK)

I need help

Extent:	1 Online-Ressource (14 p)
Series:	Documento FCE ; No. EE-20
Type of publication:	Book / Working Paper
Language:	English
Notes:	Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments January 28, 2011 erstellt
Other identifiers:	10.2139/ssrn.1750243 [DOI]
Classification:	D61 - Allocative Efficiency; Cost-Benefit Analysis ; I11 - Analysis of Health Care Markets
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10014186591